These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone. Grove A; McFarlane LC; Lipworth BJ Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man. Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol. Grove A; Lipworth BJ Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol. Wheeldon NM; McDevitt DG; Lipworth BJ Br J Clin Pharmacol; 1992 Apr; 33(4):411-6. PubMed ID: 1349493 [TBL] [Abstract][Full Text] [Related]
10. Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade. Lipworth BJ; Brown RA; McDevitt DG Br J Clin Pharmacol; 1989 Jul; 28(1):95-102. PubMed ID: 2570601 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects. Ferro A; Hall JA; Dickerson JE; Brown MJ Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585 [TBL] [Abstract][Full Text] [Related]
12. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans. Liu YL; Toubro S; Astrup A; Stock MJ Int J Obes Relat Metab Disord; 1995 Sep; 19(9):678-85. PubMed ID: 8574280 [TBL] [Abstract][Full Text] [Related]
13. A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol. Irvine NA; Lipworth BJ; McDevitt DG Br J Clin Pharmacol; 1990 Jul; 30(1):119-26. PubMed ID: 1975196 [TBL] [Abstract][Full Text] [Related]
14. Influence of beta-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol. Goldberg MR; Sciberras D; De Smet M; Lowry R; Tomasko L; Lee Y; Olah TV; Zhao J; Vyas KP; Halpin R; Kari PH; James I Br J Clin Pharmacol; 2001 Jul; 52(1):69-76. PubMed ID: 11453892 [TBL] [Abstract][Full Text] [Related]
15. Beta-blocker effects on respiratory sinus arrhythmia and baroreflex gain in normal subjects. Pitzalis MV; Mastropasqua F; Massari F; Passantino A; Totaro P; Forleo C; Rizzon P Chest; 1998 Jul; 114(1):185-91. PubMed ID: 9674468 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade. Lipworth BJ; McFarlane LC; Coutie WJ; McDevitt DG Eur J Clin Pharmacol; 1989; 37(3):297-300. PubMed ID: 2575521 [TBL] [Abstract][Full Text] [Related]
18. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man. Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912 [TBL] [Abstract][Full Text] [Related]
19. Effects of nadolol beta-blockade on blood pressure in hypertension. Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312 [TBL] [Abstract][Full Text] [Related]